Key result
A 36-year-old obese man developed severe dilated cardiomyopathy and viral myocarditis triggered by SARS-CoV-2 infection, which progressed to decompensated heart failure and death.
Why the study?
SARS-CoV-2 is an emerging cause of viral myocarditis that generates multiple complications, such as dilated cardiomyopathy.
Case Report (n=1)
SARS-CoV-2 can cause severe viral myocarditis leading to fatal dilated cardiomyopathy that may be refractory to standard heart failure therapy and systemic steroids.
Answers are grounded in this paper and cite their sources.
Documents SARS-CoV-2 myocarditis progressing to dilated cardiomyopathy in young obese males; leaves open incidence and management questions.
SARS-CoV-2 is an emerging cause of viral myocarditis that generates multiple complications, such as dilated cardiomyopathy. We describe a young, obese male patient with severe myocardial involvement by the SARS-CoV-2 virus, who presented with chest pain, elevated cardiac enzymes, non-specific electrocardiographic findings, echocardiogram with evidence of dilated heart disease with reduced ejection fraction, and subsequent verification using magnetic resonance imaging (MRI). The results of the cardiac MRI were typical of viral myocarditis. The patient did not respond to a short course of systemic steroids and the standard management for heart failure, had multiple re-admissions, and, unfortunately, died.
No takes yet. Share an insight, caveat, or question.
Cáceres-Acosta et al. (2022) conducted a case report in SARS-CoV-2 dilated cardiomyopathy (n=1). SARS-CoV-2 infection was evaluated on Clinical outcome. A 36-year-old obese man developed severe dilated cardiomyopathy and viral myocarditis triggered by SARS-CoV-2 infection, which progressed to decompensated heart failure and death.
Synapse has enriched 10 related papers. Consider them for comparative context: